Literature DB >> 6310754

Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed cells.

T F Deuel, J S Huang, S S Huang, P Stroobant, M D Waterfield.   

Abstract

The near identity of the partial amino acid sequence of human platelet-derived growth factor (PDGF) and that predicted for p28sis, the putative transforming protein of the simian sarcoma virus (SSV), suggests expression of a growth factor activity may be central for transformation by SSV. It is now reported that SSV-transformed cells but not control cells contain a growth factor activity that is identical to PDGF in immunoassay, in mitogenic dose response, and in specific mitogenic activity. The protein immunoprecipitated by antiserum to human PDGF has an apparent molecular weight of 20,000, identical to that of p20sis, the putative intracellular degradation product of p28sis. The results support the concept that expression of a PDGF-like molecule, which appears to be the product of the viral-sis gene, is responsible for the abnormal regulation of growth is SSV-transformed cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310754     DOI: 10.1126/science.6310754

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  60 in total

1.  The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors.

Authors:  A M Sizeland; A W Burgess
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

2.  Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program.

Authors:  B Weissman; S A Aaronson
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

Review 3.  Oncogenes and urological malignancies: implications for the future.

Authors:  J A Schalken; A M van den Ouweland; F M Debruijne; H F Karthaus; W J Van de Ven
Journal:  Urol Res       Date:  1988

4.  Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product.

Authors:  A Johnsson; C Betsholtz; K von der Helm; C H Heldin; B Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor.

Authors:  E A Bauer; T W Cooper; J S Huang; J Altman; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein.

Authors:  J Nilsson; M Sjölund; L Palmberg; J Thyberg; C H Heldin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Tumor products and the hypercalcemia of malignancy.

Authors:  G R Mundy; K J Ibbotson; S M D'Souza
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

8.  Inducible binding of a factor to the c-fos regulatory region.

Authors:  T E Hayes; A M Kitchen; B H Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents.

Authors:  D F Bowen-Pope; A Vogel; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

10.  Deletions in the C-terminal coding region of the v-sis gene: dimerization is required for transformation.

Authors:  M Hannink; M K Sauer; D J Donoghue
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.